SmarterDividends

MRK vs MRNA: Which Is the Better Dividend Stock?

As of Nov 1, 2026, MRK (Merck & Co., Inc.) screens as the stronger dividend stock, winning 3 of 4 head-to-head metrics. MRK offers the higher yield at 2.26%, MRK has the higher dividend-safety score.

Key facts: MRK vs MRNA

Data as of · Source: SmarterDividends data

  • As of Nov 1, 2026, Merck & Co., Inc. (MRK) has the higher forward dividend yield at 2.26%, versus 0.00% for Moderna, Inc. (MRNA).
  • By SmarterDividends' count as of Nov 1, 2026, MRK has raised its dividend for 15 consecutive years and MRNA for 0.
Cite this page

SmarterDividends, "MRK vs MRNA: Dividend Yield, Safety & Value Compared," updated Nov 1, 2026, https://smarterdividends.com/compare/mrk-vs-mrna

MetricMRKMRNA
Forward yield2.26%0.00%
Annual dividend$3.40$0.00
Payout ratio343%0%
Years of growth15 yr0 yr
5-yr dividend growth6.7%—
5-yr total return100%—
Dividend safety score88 (A)—
Fair value estimate$119.89—
Upside to fair value-20%—
Frequencyquarterly—
Market cap$371.0B$88.5B
P/E ratio151.9—

Higher yield

MRK

2.26%

Safer dividend

MRK

Grade A

Faster growth

MRK

6.7%

MRK vs MRNA — FAQ

Is MRK or MRNA a better dividend stock?

On the data, MRK wins more head-to-head categories (3 vs 1). MRK offers the higher yield (2.26%), while MRK has the stronger dividend-safety score. The right pick depends on whether you prioritise income, safety or value.

Which has a higher dividend yield, MRK or MRNA?

MRK has the higher forward dividend yield at 2.26%, versus 0.00% for MRNA.

Is MRK or MRNA safer?

Compare each stock's payout ratio, growth streak and cut history on its detail page to judge safety.

See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.